ARTICLE | Distillery Therapeutics
D-cysteine for cancer
September 19, 2025 6:37 PM UTC
Inhibiting the mitochondrial cysteine desulfurase NFS1 via supplementation with the D-enantiomer of the amino acid cysteine could help treat cancer by blocking NFS1’s extraction of sulfur groups from cysteines, which is a key step in Fe-S protein biogenesis, and thereby decreasing tumor cell proliferation.
In human lung cancer cells, a screen of L- and D-enantiomers of proteinogenic amino acids identified D-cysteine as the only candidate to inhibit colony formation and cell proliferation. ...
BCIQ Target Profiles